News Lobe Sciences acquires rare blood disease treatment company Lobe's primary focus is psychedelic medicines but the company also has an interest in treating rare disorders Rowan DunneApril 18, 2023
News Numinus Wellness YoY revenue increased five times to $5.4M Numinus clinic network generated $4.7 million in revenue during Q2 2023, showing a significant increase of 596.9 per cent from the same period last... Natalia Buendia CalvilloApril 13, 2023
News Psilocybin decreases depression in cancer patients: study Depression impacts 1 in 4 people with cancer and often becomes a debilitating aspect of their diagnosis Natalia Buendia CalvilloApril 13, 2023
News Numinus Wellness launches new psychedelics clinic licensing model for independent practitioners The company also partnered with Healing CREI to offer full operational clinics to their licensees Natalia Buendia CalvilloApril 11, 2023
Psychedelics MGC Pharma gets permission from Slovenian health authorities to research psilocybin MGC says it is the first company operating in Slovenia to obtain permission to engage in studies on the psychedelic compound Rowan DunneApril 5, 2023
Psychedelics Dutch government establishes MDMA research commission The commission will be investigating the risks and benefits associated with MDMA-assisted therapy Rowan DunneMarch 31, 2023
Psychedelics Psilocybin access denied to patients despite ongoing lawsuit against Health Canada Eight patients sued the government at the end of July last year over what they believe is a violation of constitutional rights Rowan DunneMarch 24, 2023
News Lucy Scientific and Wesana Health partner to develop CBD and psilocybin-based drug 'SANA-013' is a proprietary therapy intended to treat conditions like migraines, episodic cluster headaches and MDD Rowan DunneMarch 22, 2023
Psychedelics Oklahoma assembly passes psychedelics research bill for Veteran PTSD The state's House of Representatives approved the legislation on Thursday Rowan DunneMarch 10, 2023
News Numinus expands psychedelics research operations in Arizona This will be the company's fifth research clinic in the United States Natalia Buendia CalvilloFebruary 17, 2023